Chembio Diagn (CEMI) Tops Q1 EPS by 4c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/26/2026
Go back to Chembio Diagn (CEMI) Tops Q1 EPS by 4c
May 7, 2015 8:50 AM EDT
MEDFORD, N.Y., May 7, 2015 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leader in point-of-care diagnostic tests for infectious diseases, today reported financial results for the three months ended March 31, 2015.
John J. Sperzel III, Chembio's Chief Executive Officer, stated, "In the first quarter, we achieved multiple important growth metrics. During the period our total revenue was $6.23 million, an increase of 7.2% as compared to Q1 2014. Product revenue for Q1 2015 was $5.61 million, an increase of 14.5% as compared to Q1 2014. One of the most important measures for the Company is DPP® revenue which was $2.46 million... More
May 7, 2015 8:50 AM EDT
MEDFORD, N.Y., May 7, 2015 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leader in point-of-care diagnostic tests for infectious diseases, today reported financial results for the three months ended March 31, 2015.
John J. Sperzel III, Chembio's Chief Executive Officer, stated, "In the first quarter, we achieved multiple important growth metrics. During the period our total revenue was $6.23 million, an increase of 7.2% as compared to Q1 2014. Product revenue for Q1 2015 was $5.61 million, an increase of 14.5% as compared to Q1 2014. One of the most important measures for the Company is DPP® revenue which was $2.46 million... More
